ALSO NOTED: FDA approves MedPointe’s SOMA; EntreMed secures $20M loan; and much more…
Posted by smaranya on 17th September , 2007> The FDA has approved MedPointe’s SOMA (carisoprodol) 250 mg as a new recommended dose for the relief of discomfort associated with acute, painful musculoskeletal conditions, such as backache.